Date published: 2026-4-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

EN-1 Inhibitors

EN-1 inhibitors, belonging to a distinct chemical class, are compounds that selectively target and modulate the activity of the enzyme EN-1, also known as Enzyme-1. EN-1, a critical enzyme within cellular pathways, plays a pivotal role in catalyzing specific biochemical reactions. These inhibitors are designed to interact with the active site of EN-1, disrupting its catalytic function and thereby influencing downstream cellular processes. The molecular structure of EN-1 inhibitors is characterized by a sophisticated arrangement of atoms and functional groups, strategically positioned to engage in precise interactions with the enzyme's binding pocket. Through these interactions, EN-1 inhibitors exert their regulatory effects, potentially altering the balance of biochemical reactions in which EN-1 participates. The development of EN-1 inhibitors often involves a combination of medicinal chemistry, structural biology, and computational modeling. Researchers aim to design molecules that possess high affinity and specificity for the target enzyme while minimizing off-target effects. The understanding of the three-dimensional structure of EN-1, obtained through techniques such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, facilitates the rational design of inhibitors. Additionally, advancements in high-throughput screening techniques contribute to the identification and optimization of lead compounds within the EN-1 inhibitor class. The ongoing exploration of EN-1 inhibitors reflects a broader commitment to deciphering the intricacies of cellular processes and holds promise for diverse applications in basic research and beyond.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium chloride can inhibit GSK-3β, a kinase that is involved in the Wnt/β-catenin signaling pathway. This pathway has shown to interact with homeobox gene expressions.

GSK-3 Inhibitor IX

667463-62-9sc-202634
sc-202634A
sc-202634B
1 mg
10 mg
50 mg
$58.00
$188.00
$884.00
10
(1)

BIO (GSK-3 Inhibitor IX) can potentially influence the Wnt signaling pathway and indirectly affect EN-1.

GSK-3 Inhibitor XVI

252917-06-9sc-221691
sc-221691A
5 mg
25 mg
$180.00
$610.00
4
(1)

CHIR99021 (GSK-3 Inhibitor XVI) can affect the Wnt signaling pathway and indirectly influence EN-1.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is also a MEK inhibitor, potentially influencing the MAPK/ERK pathway and thereby EN-1.

SB 202190

152121-30-7sc-202334
sc-202334A
sc-202334B
1 mg
5 mg
25 mg
$31.00
$128.00
$454.00
45
(1)

SB202190 is a p38 MAPK inhibitor. The p38 MAPK pathway can interact with the expression of homeobox genes.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor. The JNK pathway is part of the MAPK pathway, which can interact with homeobox genes.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor. PI3K is part of the PI3K/Akt pathway, which can influence homeobox gene expressions.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another PI3K inhibitor that can influence the PI3K/Akt pathway and indirectly affect EN-1.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin is an mTOR inhibitor. The mTOR pathway can interact with homeobox gene expressions.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

Everolimus is another mTOR inhibitor that can influence the mTOR pathway and indirectly affect EN-1.